Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Hegen, H; Berek, K; Bsteh, G; Auer, M; Altmann, P; Di Pauli, F; Grams, A; Milosavljevic, D; Ponleitner, M; Poskaite, P; Schnabl, C; Wurth, S; Zinganell, A; Berger, T; Walde, J; Deisenhammer, F.
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study
EBIOMEDICINE. 2023; 91: 1-9.
Doi: 10.1016/j.ebiom.2023.104573
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Wurth Sebastian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Background Inter-individual courses of multiple sclerosis (MS) are extremely variable. The objective of this study was to investigate whether x-free light chain (x-FLC) index and serum neurofilament light (sNfL) have an additive pre-dictive value for MS disease activity. Methods Patients with early MS who had cerebrospinal fluid (CSF) and serum sampling at disease onset were followed for four years. At baseline, age, sex, disease duration, number of T2-hyperintense (T2L), and contrast-enhancing T1 lesions (CEL) on MRI were determined. During follow-up, the occurrence of a second clinical attack and start of disease-modifying treatment (DMT) were registered. x-FLC was measured by nephelometry, and x-FLC index calculated as [CSF x-FLC/serum x-FLC]/albumin quotient. sNfL was determined by single-molecule array, and age-and body-mass-index adjusted Z scores were calculated. Findings A total of 86 patients at a mean age of 33 +/- 10 years and with a female predominance of 67% were included; 36 (42%) patients experienced a second clinical attack during follow-up. Cox regression analysis adjusted for age, sex, T2L, CEL, disease and follow-up duration, and DMT use during follow-up revealed that both x-FLC index as well as sNfL Z score independently predict time to second clinical attack. The chance for freedom of relapse within 12 months was 2% in patients with high levels of x-FLC index (>100) and high sNfL Z score (>3), 30% in patients with high x-FLC index (>100) and lower sNfL Z score (<= 3), 70% in patients with lower x-FLC index (<= 100) but high sNfL Z score (>3), and 90% in patients with lower levels of x-FLC index (<= 100) and sNfL Z score (<= 3). Interpretation x-FLC index and sNfL Z score have an additive predictive value for early MS disease activity that is independent of known predictors.
- Find related publications in this database (Keywords)
-
Cerebrospinal fluid
-
Kappa free light chain
-
Neurofilament light
-
Multiple sclerosis
-
Disease activity
-
Prediction